Kidney Transplantation
Part of NephTimes
Advertisement
American Society of Nephrology leaders met with Congress to urge increased funding to support organ transplantation.
Few data are available on the association between primary kidney disease and donor relatedness with transplant outcomes.
Researchers compared the overall and site-specific risk of fracture among living kidney donors.
The FDA granted Orphan Drug Designation for felzartamab to treat antibody-mediated rejection in kidney transplant recipients.
The EnAKT LKD trial was designed to target barriers preventing eligible patients from receiving a kidney transplant.
Kidney transplant recipients are living longer, and their transplanted kidneys are lasting longer, researchers said.
A Boston area man became the first to receive a genetically modified pig kidney via transplant.
Authorities are investigating whether several nonprofit organ procurement organizations defrauded the US government.
Studies have suggested physical activity has beneficial effects on health-related outcomes in kidney transplant patients.
Researchers examined racial differences in rates of living donor kidney transplant, including center characteristics.
The FDA gave orphan drug designation to UNI-494 for the prevention of delayed graft function in kidney transplant patients.
The American Kidney Fund released its fourth annual report card ranking states' support of living organ donation.
Potential living kidney donors may be unprepared for possible negative outcomes following donation.
There was no association between kidneys from active COVID-19-positive donors procured in 2023 and higher odds of nonuse.
Metformin users had a lower risk of graft failure, even after accounting for the competing risk of all-cause mortality.
No recipient tumors had a histological type matching that of the donor brain tumor.
The actual burden of vaccine-preventable infections among recipients of solid organ transplants is unclear.
At 1 year after transplant, patient and graft survival was 100%.
Results of an analysis to characterize the sequelae of COVID-19 infection among kidney transplant recipients.
Participants were analyzed for antibodies to the SARS-CoV-2 spike protein receptor-binding domain.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.